Dali Zhao

Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

Bo Zhai, Fengli Hu, Xian Jiang et al. · Molecular Cancer Therapeutics · 2014 · 282 citations

Immunology, Cell Death, Cancer Biology +16

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

Dali Zhao, Bo Zhai, Changjun He et al. · Cellular Signalling · 2014 · 137 citations · Full text

2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2

Li Ma, Guangxin Li, Huaqiang Zhu et al. · Cancer Letters · 2014 · 89 citations

Oncology, Hepatology, Medicine +6

Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells

Peng Han, Hali Li, Xian Jiang et al. · Molecular Oncology · 2017 · 70 citations · Full text

Sorafenib-resistant Hcc, Dual Inhibition, Medicine +13

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress

Bo Zhai, Fengli Hu, Haijiang Yan et al. · PLoS ONE · 2015 · 60 citations · Full text

Chemoprevention Strategy, Akt Activation, Immunology +21